Browsing MIT Theses by Author "Gabriela, Monica"
Now showing items 1-1 of 1
-
Drug Substance and Drug Product Manufacturing Strategy Assessment for siRNAs
Gabriela, Monica (Massachusetts Institute of Technology, 2021-06)Amgen currently has its first siRNA program, Asset #1 in phase 2 clinical trials. Until recently, Amgen has been outsourcing the Drug Substance (DS) and Drug Product (DP) manufacturing to external manufacturers, but with ...